Aavis Pharmaceuticals Inc

About

Aavis Pharmaceuticals Inc is a USFDA-approved, privately owned pharmaceutical company strategically located in Hoschton, Georgia, serving as a subsidiary of Senores Pharmaceuticals Ltd. Specializing as a Contract Development and Manufacturing Organization (CDMO/CMO), the company delivers proficiently researched high-quality pharmaceuticals with a focus on complex formulations and enhanced therapeutic efficiency. The company excels in generic drug development, offering comprehensive research and development services for both immediate and controlled release oral solid dosage forms. Their core capabilities encompass analytical method development and validation, stability studies, and seamless scale-up from research to commercial manufacturing phases. Aavis Pharmaceuticals provides critical clinical study support, enabling pharmaceutical partners to navigate complex regulatory requirements effectively. With specialized expertise in pharmaceutical formulation research, the organization develops innovative formulations designed to improve patient compliance and therapeutic outcomes. Their contract research services support clients throughout the drug development lifecycle, from initial concept to market-ready products. The company maintains rigorous quality standards while delivering cost-effective solutions for pharmaceutical manufacturers seeking reliable CDMO partnerships. Located in the thriving Atlanta region, Aavis Pharmaceuticals leverages advanced manufacturing technologies and regulatory expertise to serve domestic and international markets, establishing itself as a trusted partner in the competitive pharmaceutical manufacturing landscape.